Skip navigation

Movianto UK, one of the UK’s leading pharmaceutical warehousing and distribution companies, has just signed a major contract with Intercytex, the organisation responsible for inventing the revolutionary skin repair procedure using a laboratory-manufactured replacement for human skin.

The contract with Movianto UK is for the transport and distribution of its new product, VAVELTA® - a facial rejuvenation product intended to improve the appearance of facial imperfections. The product VAVELTA® has collagen enhancing properties and is injected directly into the target area. Vavelta will be used in a limited number of centres which have expertise in the use of this type of product.
Intercytex Programme Director, Richard Hall commented on their choice of Movianto UK: “We chose Movianto UK because of their impeccable service, customer support, and industry expertise. We were impressed by the focus on health sector products and the volume of business experience exhibited. In addition, their chilled facility for 2 to 8°C delivery service is a valuable option for us.” He continued, “VAVELTA® is shipped in its own dedicated, cooled container, called a Nanocool. This maintains 2 to 8°C under a variety of ambient conditions. Movianto UK provides controlled ambient storage conditions at its warehouses and this was of interest to Intercytex. Furthermore, the option to use the chilled cabinet within their vehicles and warehouses could be useful to us in the future.” concluded Mr Hall.
“The Intercytex contract is an exciting win for Movianto UK. We are looking forward to a successful partnership with the potential to further develop through their ground breaking portfolio of products” commented Bob Goulborn, Business Development Manager for Movianto UK.

Distribution of Intercytex’s VAVELTAÒ will initially focus on private clinics across the UK which are registered by the Healthcare Commission and operated by cosmetic surgeons, GPs and dermatologists.
About Movianto UK
Movianto UK is a subsidiary of the Movianto Group, the logistics and distribution business unit of Celesio AG. With its more than 800 strong team throughout the UK, Movianto UK can deliver to every UK hospital and pharmaceutical wholesaler every day via its network of 8 strategically located depots. The company also delivers chilled and ambient medicines and healthcare products to supermarkets, pharmacists, GPs, nursing homes and direct to patients’ homes on a next day basis.

About Movianto Group
Movianto provides the pharmaceutical, biotechnology and healthcare industry with innovative logistics and distribution solutions across a network of nine European countries. Movianto’s 400 international clients, including the world’s ten largest pharmaceutical manufacturers, benefit from a broad range of pharmaceutical logistics services and the variety of distribution models at national, regional and European level. Providing consistently high levels of quality and securing transparency of the supply chain are at Movianto’s highest priority. Clients are able to profit from the specialist knowledge offered by Movianto’s more than 1,500 employees. For further information, please visit
Date of Issue: 4 October 2007
Issued on behalf of: Movianto UK Limited
Progress Park
MK42 9XE
T: 0870 870 0190
F: 01234 248 700

Issued by: Beyond PR Limited
7200 The Quorum
Oxford Business Park North
Garsington Road
T: 0845 634 4259
F: 0870 141 0443

For further information please contact Andrew Fellows or Andrea Ratcliffe at Beyond Pr on the number above or at /

This press release was distributed by ResponseSource Press Release Wire on behalf of Beyond PR (Oxford) in the following categories: Medical & Pharmaceutical, Transport & Logistics, for more information visit